Test | N-3 PUFA | Placebo | ΔN-3 vs. Δ PLA (% ±90 % CL) | Inference | ||
---|---|---|---|---|---|---|
Visit 1 | Visit 2 | Visit 1 | Visit 2 | |||
Squat Jump (cm) | 34.6 ± 7.7 | 34.7 ± 6.7 | 36.6 ± 3.1 | 38.0 ± 7.1 | 2.4 ± 9.3 | Unclear |
Counter Movement Jump (cm) | 43.5 ± 9.4 | 43.6 ± 7.2 | 45.5 ± 4.7 | 45.7 ± 6.2 | 1.4 ± 1.4 | Unclear |
Push-ups 1 | 50 ± 14 | 51 ± 13 | 49 ± 13 | 51 ± 14 | 1 ± 5.8 | Unclear |
Push-ups 2 | 23 ± 11 | 24 ± 10 | 25 ± 10 | 27 ± 12 | 1 ± 6.6 | Unclear |
Back Squat | 13 ± 4 | 15 ± 4 | 12 ± 2 | 15 ± 4 | 5 ± 19 | Unclear |
Wingate PP (W) | 841.30 ± 160.50 | 838 ± 176.84 | 835 ± 136.65 | 847.26 ± 130.25 | 2.17 ± 4.7 | Unclear |
Wingate Average Power (W) | 593.1 ± 95.78 | 599.7 ± 92.65 | 611.3 ± 90.69 | 616.1 ± 104.44 | 0.74 ± 2.9 | Unclear |
Wingate Power Drop (%) | 54.8 ± 9.54 | 54.6 ± 10.33 | 49.1 ± 5.82 | 53.0 ± 5.46 | 4.76 ± 3.4 | Very likely beneficial |
250 kJ Time Trial (sec) | 1133.2 ± 296.1 | 1126.9 ± 265.7 | 1093.8 ± 269.8 | 1116.7 ± 269.6 | 1.96 ± 4.8 | Unclear |